CUOMO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 5.260
EU - Europa 5.220
AS - Asia 3.481
SA - Sud America 786
AF - Africa 243
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15.036
Nazione #
US - Stati Uniti d'America 5.102
IT - Italia 1.496
SG - Singapore 1.164
RU - Federazione Russa 1.048
CN - Cina 963
GB - Regno Unito 938
BR - Brasile 622
IE - Irlanda 536
VN - Vietnam 371
HK - Hong Kong 267
FR - Francia 252
SE - Svezia 234
KR - Corea 185
DE - Germania 178
IN - India 147
UA - Ucraina 124
FI - Finlandia 93
ZA - Sudafrica 92
CA - Canada 91
BD - Bangladesh 79
AR - Argentina 70
NL - Olanda 69
TR - Turchia 65
MX - Messico 47
ES - Italia 46
KE - Kenya 46
PL - Polonia 40
AU - Australia 36
JP - Giappone 32
IQ - Iraq 31
AT - Austria 30
NG - Nigeria 25
CI - Costa d'Avorio 22
EC - Ecuador 22
CH - Svizzera 19
ID - Indonesia 19
PE - Perù 19
VE - Venezuela 18
PH - Filippine 16
PK - Pakistan 16
MA - Marocco 15
GR - Grecia 14
MY - Malesia 14
SA - Arabia Saudita 14
UZ - Uzbekistan 12
CZ - Repubblica Ceca 11
EG - Egitto 11
HU - Ungheria 11
CL - Cile 10
CO - Colombia 10
IR - Iran 10
PT - Portogallo 10
DK - Danimarca 9
TH - Thailandia 9
DZ - Algeria 8
PY - Paraguay 8
IM - Isola di Man 7
RO - Romania 7
TW - Taiwan 7
UG - Uganda 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
JO - Giordania 6
LT - Lituania 6
NP - Nepal 6
OM - Oman 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
BG - Bulgaria 5
NZ - Nuova Zelanda 5
TN - Tunisia 5
AL - Albania 4
AZ - Azerbaigian 4
CR - Costa Rica 4
ET - Etiopia 4
IL - Israele 4
KG - Kirghizistan 4
KZ - Kazakistan 4
UY - Uruguay 4
BF - Burkina Faso 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
KW - Kuwait 3
MD - Moldavia 3
NO - Norvegia 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SI - Slovenia 3
BH - Bahrain 2
BO - Bolivia 2
CY - Cipro 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
LB - Libano 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
Totale 15.018
Città #
Southend 771
Dallas 731
Singapore 544
Dublin 527
Ashburn 417
Fairfield 357
Santa Clara 355
Moscow 334
Houston 267
Hefei 263
Hong Kong 247
Beijing 241
Siena 226
San Jose 212
Chandler 190
Seoul 174
Florence 171
Woodbridge 158
Wilmington 140
Milan 139
Seattle 118
Cambridge 115
Council Bluffs 107
Jacksonville 103
Ho Chi Minh City 102
Rome 97
Los Angeles 93
The Dalles 93
New York 81
Princeton 78
Lauterbourg 75
Johannesburg 73
Dong Ket 71
Hanoi 69
São Paulo 65
Ann Arbor 63
Helsinki 56
Munich 48
Bengaluru 41
Redondo Beach 41
Buffalo 37
Orem 37
Nairobi 34
Nanjing 33
Rio de Janeiro 33
San Diego 31
San Mateo 29
Boardman 26
Bologna 25
London 25
Warsaw 25
Washington 25
Chennai 24
Málaga 24
Nuremberg 24
Abuja 23
Brescia 23
Chicago 23
Abidjan 22
Brooklyn 22
Montreal 22
Naples 21
San Francisco 21
Sanliurfa 21
Cinisello Balsamo 20
Lappeenranta 20
Tokyo 20
Prato 19
Amsterdam 18
Da Nang 18
Manchester 18
Mumbai 17
Turin 17
Columbus 16
Trento 16
Vienna 16
Campinas 15
Frankfurt am Main 15
Lima 15
Paris 15
Tianjin 15
Toronto 15
Cape Town 14
Dhaka 14
Stockholm 14
Boston 13
Denver 13
Livorno 13
Mexico City 13
Shanghai 13
Sydney 13
Belo Horizonte 12
Guangzhou 12
Norwalk 12
Palermo 12
Phoenix 12
Tashkent 12
Atlanta 11
Katwijk 11
Padova 11
Totale 9.213
Nome #
Trazodone: a multifunctional antidepressant. Evaluation of its properties and real-world use 568
Clinical effectiveness of parenteral trazodone for the management of psychomotor activation in patients with bipolar disorder 523
"TREATMENT-RESISTANT DEPRESSION" AND USE OF INTRAVENOUS KETAMINE AND INTRANASAL ES-KETAMINE 418
Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice 401
Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder 357
Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice 302
Antidepressant and pro-motivational effects of repeated lamotrigine treatment in a rat model of depressive symptoms 290
The Microbiome: A New Target for Research and Treatment of Schizophrenia and its Resistant Presentations? A Systematic Literature Search and Review 260
Drug safety evaluation of aripiprazole in bipolar disorder 260
Feasibility, adherence and efficacy of liraglutide treatment in a sample of individuals with mood disorders and obesity 243
Advances in treatment for postpartum major depressive disorder 238
Prevalence and correlates of Vitamin D deficiency in a sample of 290 inpatients with mental illness 219
Effectiveness of light therapy as adjunctive treatment in bipolar depression: A pilot study 211
Does higher severity really correlate with a worse quality of life in obsessive-compulsive disorder? A meta-regression 209
Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice 207
Treatment persistence in patients with schizophrenia treated with lurasidone in Italian clinical practice 205
A new approach for seasonal pattern: is it related to bipolarity dimension? Findings from an Italian multicenter study 205
Therapeutic Potential of Saffron Extract in Mild Depression: A Study of Its Role on Anhedonia in Rats and Humans 202
Prevalence, chronicity, burden and borders of bipolar disorder 201
A Systematic Review on Ketamine and Esketamine for Treatment-Resistant Depression and Suicidality in Adolescents: A New Hope? 200
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 200
S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): A clinician-oriented systematic review 196
Internet use by older adults with bipolar disorder: international survey results 192
Mood spectrum symptoms during a major depressive episode: Differences between 145 patients with bipolar disorder and 155 patients with major depressive disorder. Arguments for a dimensional approach 189
Perfenazina, amitriptilina e perfenazina-amitriptilina: Ruolo nella pratica clinica [Perphenazine, amitriptyline and perphenazine-amitriptyline: Role in clinical practice] 188
Using sertraline in postpartum and breastfeeding: balancing risks and benefits 188
The neural bases of social cognition in major depressive disorder: a review [La cognizione sociale nel disturbo depressivo maggiore: Una rassegna sulle basi neurali] 187
On the centrality of mixed features in mood disorders: Listening to Kraepelin and Weygandt and moving forward 185
Accuracy of self-assessment of real-life functioning in schizophrenia 181
Exploring treatment strategies for mood stabilization in patients with major depressive disorder and mixed features 180
Neuroticism and conscientiousness moderate the effect of oral medication beliefs on adherence of people with mental illness during the pandemic 179
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 179
Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions: Pharmacology and clinical practice 177
Biomarkers, Inflammation, and Bipolar Disorder: Association Between the Improvement of Bipolar Disorder Severity and the Improvement in C-Reactive Protein Levels After 7 Days of Inpatient Treatment 176
Mental health in Italy after two years of COVID-19 from the perspective of 1281 Italian physicians: looking back to plan forward 173
The impact of COVID-19 pandemic in patients with a diagnosis of Oral Lichen Planus: Pain perception and psychological profile analysis 165
Validation of the Oxford Depression Questionnaire: Sensitivity to change, minimal clinically important difference, and response threshold for the assessment of emotional blunting 162
Psychological interventions for post-traumatic stress disorder in women survivors of intimate partner violence: A systematic review and meta-analysis 159
Is intravenous valproate more efficacious than oral valproate for inpatients with bipolar I disorder with a manic or depressive episode and concomitant symptoms of opposite polarity? 159
Safety of psychotropic medications in people with COVID-19: Evidence review and practical recommendations 155
Efficacy of topiramate in treating obsessive compulsive disorder: A systematic review and meta-analysis 152
Two-Injection Start Regimen of Long-Acting Aripiprazole in 133 Patients With Schizophrenia 149
Effectiveness and Tolerability of Supratherapeutic Dosing of Vortioxetine in Patients With Treatment-Resistant Depression 149
Five-year follow-up of first-episode depression treated with psychodynamic psychotherapy or antidepressants 148
Which mixed depression model? A comparison between DSM-5-defined mixed features and Koukopoulos' criteria 148
La responsabilità dello psichiatra [Duties and liabilities for psychiatrists] 146
Symptom modulation and tolerability of intravenous ketamine in treatment-resistant bipolar depression: A retrospective study 145
COVID-19 Diary from a Psychiatry Department in Italy 145
Perspectives on the impact of vortioxetine on the treatment armamentarium of major depressive disorder 142
Treating major depressive disorder with mixed features 140
Treating schizophrenia with cariprazine: from clinical research to clinical practice. Real world experiences and recommendations from an International Panel 138
Lurasidone in adolescents and adults with schizophrenia: from clinical trials to real-world clinical practice 137
Association between polarity of first episode and solar insolation in bipolar I disorder 135
Lamotrigine in bipolar disorder: preventing depression to treat the disease 135
null 134
Practical guidance for prescribing trazodone extended-release in major depression 133
Worldwide prevalence of obsessive-compulsive symptoms during the COVID-19 pandemic: A systematic review and meta-analysis 132
Exploration of mood spectrum symptoms during a major depressive episode: The impact of contrapolarity-Results from a transdiagnostic cluster analysis on an Italian sample of unipolar and bipolar patients 128
Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses 128
QTc interval diurnal variations in patients treated with psychotropic medications: implications for the evaluation of drug induced QTc changes 126
Effectiveness of Intramuscular Chlorpromazine for Rapid Treatment of Psychomotor Agitation: A Naturalistic, Retrospective, and Observational Study 124
Principi di farmacodinamica e farmacocinetica nello switch tra antipsicotici: focus su cariprazina 118
Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis 117
Exploratory study of ultraviolet B (UVB) radiation and age of onset of bipolar disorder 116
Unraveling the Boundaries, Overlaps, and Connections between Schizophrenia and Obsessive–Compulsive Disorder (OCD) 116
Insights into the Incidence, Course, and Management of Lithium-Induced Hypothyroidism in Real-World Psychiatric Practice in Italy 114
Medico-legal implications of mobbing: a case law [Riflessioni medico-legali su un caso giudiziario di mobbing] 114
The influence of autistic symptoms on social and non-social cognition and on real-life functioning in people with schizophrenia: Evidence from the Italian Network for Research on Psychoses multicenter study 112
Erratum: Safety of psychotropic medications in people with COVID-19: Evidence review and practical recommendations (BMC Medicine (2020) 18 (215) DOI: 10.1186/s12916-020-01685-9) 112
Personalized treatment of depression phenotypes: Role of trazodone in depression with insomnia 112
Neurophysiological correlates of ketamine-induced dissociative state in bipolar disorder: insights from real-world clinical settings 109
Vulnerabilities in Mental Health due to Covid-19 Pandemic: The Response of the Italian Physicians 108
Variations in seasonal solar insolation are associated with a history of suicide attempts in bipolar I disorder 107
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 107
Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release 104
Investigating the Relationship between Autistic Traits, Ruminative Thinking, and Suicidality in a Clinical Sample of Subjects with Bipolar Disorder and Borderline Personality Disorder 103
Drug-drug interactions between COVID-19 therapeutics and psychotropic medications 103
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 101
Personalized medicine with extended-release trazodone and/or once-a-day trazodone: From research trials to clinical practice 98
Treatment persistence with aripiprazole once monthly: a 4-year follow-up 95
Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia 94
Autistic symptoms in unaffected first-degree relatives of people with schizophrenia: results from the Italian Network for Research on Psychoses multicenter study 93
Interplay Among Psychopathologic Variables, Personal Resources, Context-Related Factors, and Real-life Functioning in Individuals With Schizophrenia: A Network Analysis 92
Impact of menstrual cycle events on bipolar disorder course: a narrative review of current evidence 92
Individualized strategies for depression: narrative review of clinical profiles responsive to vortioxetine 92
Rethinking the role of trazodone in the different depressive dimensions 90
Pocket Guide to Practical Psychopharmacology : Lithium and Anticonvulsants in Psychiatric Practice 86
Practical prescribing with COVID-19 medications and psychotropics: a guide to pharmacokinetic interactions 85
Prolonged grief disorder in psychiatric patients: Assessing the PG-13-R scale and clinical implications 79
Employment and Social Security/Insurance among patients affected by mental disorders in Italy: A descriptive multi-center study 77
Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the "real-life" 75
Intravenous trazodone for the treatment of psychomotor agitation and associated symptoms in major depressive disorder patients experiencing a depressive episode with mixed features 68
Liquid antipsychotics in the management of psychomotor agitation: a focus on promazine 66
Rehabilitation in Adults with Complex Psychosis: A Clinician-Oriented Narrative Review of Multidimensional Approaches to Functional Recovery 11
Valproate-enhanced Protocols for alcohol withdrawal syndrome: a brief review and retrospective study of efficacy and the ability to reduce benzodiazepine use 7
Long-Acting Injectable Antipsychotics in Adolescents: From Current Evidence and Gaps to Clinical Practice 5
Inflammatory and Immune Biomarkers in Mood Disorders: From Mechanistic Pathways to Clinical Translation 5
Efficacy and Tolerability of Bupropion in Major Depressive Disorder with Comorbid Anxiety Symptoms: A Systematic Review 4
Totale 15.390
Categoria #
all - tutte 47.457
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.457


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021160 0 0 0 0 0 0 0 0 0 0 0 160
2021/2022751 32 82 57 74 42 40 63 46 82 48 58 127
2022/2023937 55 60 133 86 58 151 29 143 95 44 39 44
2023/20241.378 77 36 96 90 50 284 341 42 18 99 113 132
2024/20253.334 112 146 227 329 366 283 143 141 255 255 347 730
2025/20266.273 546 892 653 785 1.042 294 698 279 252 393 343 96
Totale 15.390